Pharmaceutical Executive Europe - October 2008 - (Page 11)

Strategy Fundamentals pharmaceutical sector, for example, assumptions that the ‘best’ molecule wins in the market leads to high value placed on technical knowledge and data and a dominance of ‘positivist’ scientific methods even in non-scientific areas like strategy and marketing. Practically important to pharmaceutical executives at the moment are three implications of Schein’s work. First, culture only changes very slowly and then only from the top. This is a lesson lost on many companies who plan outright cultural change into their annual plan and delegate it to middle managers. Second, because assumptions drive culture, it is useless to fiddle about with artefacts like job titles, language or organisation charts. The only cultural change that really works is that which begins with changing core assumptions. Usually, this is only possible when the leaders of the company use some kind of cultural symbolism to communicate to the troops that things have changed. Sanofi’s recent firing of most of the sales team in some countries is an example of this, as is GSK’s restructuring of its R&D organisation. However, firms attempting cultural change need also to be aware of the third implication of Schein’s work. Cultural assumptions, he said, only survive because they have worked in the past. Executives change culture at the risk of throwing the baby out with the bath water. So, whilst my platitude-full acquaintance was not wrong, his all-tocommon view of culture isn’t practically useful to executives. Where they perceive culture to be the issue, they would be better to read Schein and other substantial work on company culture. Further Reading E. H. Schein, “What is Culture?,” in Reframing Organizational Culture, First Edn, P. J. Frost et al., Eds., Sage, Newbury Park, California, 1991, pp. 243–253. B. D.Smith, “Culture Clash,” Marketing Business, July/August 2002, pp. 33–35. Available free on request from the author. 12 Executive Recruitment ‘Downshifting’ can be a good move for the ambitious 15 Executive Recruitment The value of recruiting experts on an as needed basis 19 Meet unmet needs Natalie Douglas on named patient programmes 22 Pharma in Turkey Interviews with the country’s leading executives

Table of Contents Feed for the Digital Edition of Pharmaceutical Executive Europe - October 2008

Pharmaceutical Executive Europe - October 2008 Contents News and Analysis Calendar BioFutures Strategy Fundamentals Executive Recruitment: Small Company, Big Career Executive Recruitment: Instant Pharma Named Patient Programmes Executive Review: Turkey

Pharmaceutical Executive Europe - October 2008

Pharmaceutical Executive Europe - October 2008 - Pharmaceutical Executive Europe - October 2008 (Page 1) Pharmaceutical Executive Europe - October 2008 - Contents (Page 2) Pharmaceutical Executive Europe - October 2008 - News and Analysis (Page 3) Pharmaceutical Executive Europe - October 2008 - News and Analysis (Page 4) Pharmaceutical Executive Europe - October 2008 - News and Analysis (Page 5) Pharmaceutical Executive Europe - October 2008 - Calendar (Page 6) Pharmaceutical Executive Europe - October 2008 - BioFutures (Page 7) Pharmaceutical Executive Europe - October 2008 - BioFutures (Page 8) Pharmaceutical Executive Europe - October 2008 - BioFutures (Page 9) Pharmaceutical Executive Europe - October 2008 - Strategy Fundamentals (Page 10) Pharmaceutical Executive Europe - October 2008 - Strategy Fundamentals (Page 11) Pharmaceutical Executive Europe - October 2008 - Executive Recruitment: Small Company, Big Career (Page 12) Pharmaceutical Executive Europe - October 2008 - Executive Recruitment: Small Company, Big Career (Page 13) Pharmaceutical Executive Europe - October 2008 - Executive Recruitment: Small Company, Big Career (Page 14) Pharmaceutical Executive Europe - October 2008 - Executive Recruitment: Instant Pharma (Page 15) Pharmaceutical Executive Europe - October 2008 - Executive Recruitment: Instant Pharma (Page 16) Pharmaceutical Executive Europe - October 2008 - Executive Recruitment: Instant Pharma (Page 17) Pharmaceutical Executive Europe - October 2008 - Executive Recruitment: Instant Pharma (Page 18) Pharmaceutical Executive Europe - October 2008 - Named Patient Programmes (Page 19) Pharmaceutical Executive Europe - October 2008 - Named Patient Programmes (Page 20) Pharmaceutical Executive Europe - October 2008 - Named Patient Programmes (Page 21) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 22) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 23) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 24) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 25) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 26) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 27) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 28) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 29) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 30) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 31) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 32) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 33) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 34) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 35) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 36) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 37) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC1) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC2) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC3) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC4) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC5) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC6) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC7) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC8) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC9) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC10) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC11) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC12) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC13) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC14) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC15) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC16) http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20091124http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20091110http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20091027http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20091013http://digital.findpharma.com/nxtbooks/advanstaruk/PEE_DIGEST_20090930http://digital.findpharma.com/nxtbooks/advanstaruk/PEE_digest_20090916http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090902http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090825http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090819http://digital.findpharma.com//nxtbooks/advanstaruk/pee_digest_20090812http://digital.findpharma.com//nxtbooks/advanstaruk/pee_digest_20090805http://digital.findpharma.com//nxtbooks/advanstaruk/pee_digest_20090729http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090721http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090715http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090708http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090701http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090624http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090617http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090610http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090602http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090526http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090519http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090512http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090505http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_southafricahttp://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090429http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090422http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090415http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090408http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090401_v2http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090401http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090325http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090318http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090311http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090304http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090224http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090218http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090211http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090203http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090128http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090121http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090114http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope1008http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope-ims1008http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0908http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0808http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0708http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0608http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope-imssales0508http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0508http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0408http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0308http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0208http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope-imssales0208http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0108http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope-ims1207http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope1107http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope1007http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope-imsoncology0907http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0407http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0307http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope1206http://www.nxtbookMEDIA.com

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.